EMAIL THIS PAGE TO A FRIEND

PloS one

Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.


PMID 25427253

Abstract

We have generated a novel monoclonal antibody targeting human FGFR1c (R1c mAb) that caused profound body weight and body fat loss in diet-induced obese mice due to decreased food intake (with energy expenditure unaltered), in turn improving glucose control. R1c mAb also caused weight loss in leptin-deficient ob/ob mice, leptin receptor-mutant db/db mice, and in mice lacking either the melanocortin 4 receptor or the melanin-concentrating hormone receptor 1. In addition, R1c mAb did not change hypothalamic mRNA expression levels of Agrp, Cart, Pomc, Npy, Crh, Mch, or Orexin, suggesting that R1c mAb could cause food intake inhibition and body weight loss via other mechanisms in the brain. Interestingly, peripherally administered R1c mAb accumulated in the median eminence, adjacent arcuate nucleus and in the circumventricular organs where it activated the early response gene c-Fos. As a plausible mechanism and coinciding with the initiation of food intake suppression, R1c mAb induced hypothalamic expression levels of the cytokines Monocyte chemoattractant protein 1 and 3 and ERK1/2 and p70 S6 kinase 1 activation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

I7018
3-Isobutyl-1-methylxanthine, BioUltra, ≥99%
C10H14N4O2
I5879
3-Isobutyl-1-methylxanthine, ≥99% (HPLC), powder
C10H14N4O2
A0325000
Alanine, European Pharmacopoeia (EP) Reference Standard
C3H7NO2
C2155000
Cholesterol, European Pharmacopoeia (EP) Reference Standard
C27H46O
PHR1533
Cholesterol, Pharmaceutical Secondary Standard; Certified Reference Material
C27H46O
47127-U
Cholesterol solution, certified reference material, 10 mg/mL in chloroform
C27H46O
409332
Cobalt(II) chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
Cl2Co
449776
Cobalt(II) chloride, anhydrous, beads, −10 mesh, 99.9% trace metals basis
Cl2Co
D0700000
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
1176007
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
C22H29FO5
46165
Dexamethasone, VETRANAL, analytical standard
C22H29FO5
31375
Dexamethasone, tested according to Ph.Eur.
C22H29FO5
PHR1526
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
C22H29FO5
Y0001593
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
Y0001177
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
A7502
DL-Alanine, ≥99% (HPLC)
C3H7NO2
W381810
DL-Alanine, ≥99%, FCC, FG
C3H7NO2
G3157
Glucagon, from porcine pancreas, powder, γ-irradiated, cell culture tested
C153H225N43O49S
G2044
Glucagon, synthetic, powder, cell culture tested
C153H225N43O49S
G1774
Glucagon, ≥95% (HPLC), powder, synthetic
C153H225N43O49S
Y0000858 Isoflurane, European Pharmacopoeia (EP) Reference Standard
C3H2ClF5O